Epithelial-mesenchymal transition and drug resistance in breast cancer (Review)

Author： Huang Jing Li Hongzhong Ren Guosheng

E-ISSN： 1791-2423|47|3|840-848

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.47, Iss.3, 2015-09, pp. : 840-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epithelial-Mesenchymal Transition-A Hallmark of Breast Cancer Metastasis

By Wang Yifan Zhou Binhua P.

Cancer Hallmarks, Vol. 1, Iss. 1, 2013-03 ,pp. : 38-49

American Scientific Publishers

Access to resources Recommend Favorite

Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells

By Heery Richard Finn Stephen P. Cuffe Sinead Gray Steven G.

Cancers, Vol. 9, Iss. 4, 2017-04 ,pp. : 38-38

MDPI

Access to resources Recommend Favorite

Epithelial––mesenchymal transition in development and cancer

By Micalizzi Douglas S Ford Heide L

Future Oncology, Vol. 5, Iss. 8, 2009-10 ,pp. : 1129-1143

Future Medicine

Access to resources Recommend Favorite

STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits

International Journal of Oncology, Vol. 44, Iss. 2, 2014-01 ,pp. : 403-411

Spandidos Publications

Access to resources Recommend Favorite

MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer

By Liang Yong-Jun

Carcinogenesis, Vol. 34, Iss. 3, 2013-03 ,pp. : 713-722

Oxford University Press

Access to resources Recommend Favorite